| Home | E-Submission | Sitemap | Contact Us |  
Journal of Neurocritical Care > Volume 11(2); 2018 > Article
Kang, Kang, Roh, Yeom, Shim, Kim, Lee, Kim, Park, Kim, Kim, Choi, Kwon, Kang, and Baik: Feasibility, Safety, and Follow-up Angiographic Results of Endovascular Treatment for Non-Selected Ruptured Intracranial Aneurysms Under Local Anesthesia with Conscious Sedation



At most centers, general anesthesia (GA) has been preferred for endovascular treatment (EVT) of ruptured intracranial aneurysms (RIAs). In this study, we analyzed procedural results, clinical outcomes, and follow-up angiographic findings for patients undergoing EVT for RIA under local anesthesia (LA) with conscious sedation (CS).


We retrospectively evaluated 308 consecutive patients who underwent EVT for RIAs at a single institution between June 2009 and February 2017. EVT under LA with CS was considered for all patients with aneurysmal subarachnoid hemorrhage, regardless of Hunt and Hess (HH) scale score.


EVT was performed for 320 aneurysms in 308 patients with subarachnoid hemorrhages. The mean patient age was 55.5±12.6 years. Moderate (III) and poor (IV, V) HH grades were observed in 75 (24.4%) and 77 patients (25%), respectively. Complete occlusion immediately after EVT was achieved for 270 (84.4%) of 320 aneurysms. Thromboembolic complications and intraprocedural ruptures occurred in 25 (7.8%) and 14 cases (4.3%), respectively. The morbidity rate at discharge (as defined by a modified Rankin scale score of 3 or greater) was 27.3% (84/308), while the mortality rate was 11.7% (36/308). Follow-up angiographic results were available for 210 (68.1%) of 308 patients. Recanalization was observed in 64 (29.3%) of 218 aneurysms in 210 patients.


Based on our experience, EVT for RIAs under LA with CS was feasible, regardless of the clinical grade of the subarachnoid hemorrhage. Complication rates and follow-up angiographic results were also comparable to those observed when GA was used to perform the procedure.


Since the International Subarachnoid Aneurysm Trial demonstrated its safety and efficacy, endovascular treatment (EVT) involving coil embolization has been a mainstay of treatment for both unruptured and ruptured intracranial aneurysms [1]. At most centers, coil embolization for ruptured intracranial aneurysm (RIA) is performed under general anesthesia (GA), which provides optimal conditions for the procedure [2]. However, GA does not allow the evaluation of neurological status during the procedure, and several complications are associated with mechanical ventilation and anesthetics [3].
At our institution, we performed EVT under local anesthesia (LA) with conscious sedation (CS) for all patients with RIA, regardless of the clinical severity of the subarachnoid hemorrhage (SAH). However, few studies have evaluated the procedural results of patients treated in this manner [4,5]. Furthermore, the long-term follow-up angiographic results of RIAs treated by EVT under LA with CS have not been reported. Therefore, in the present study, we evaluated the procedural results, clinical outcomes, and long-term follow-up angiographic findings of patients undergoing EVT for RIAs under LA with CS.


Patients and data collection

We retrospectively evaluated findings from 308 consecutive patients with aneurysmal SAHs who underwent EVT at a single institution between June 2009 and February 2017. This study was approved by the appropriate Institutional Review Board (IRB no. 05-2018-176), which waived the requirement for informed consent due to the retrospective nature of the study. Patients’ demographics, initial neurological severity, length of hospital stay, clinical outcome at discharge, and mortality were extracted from each patient’s electronic medical records. At the time of EVT for RIA, the following initial angiographic data were also collected: location and size of the treated aneurysms, height-to-neck ratio of the aneurysms, and immediate angiographic results following the procedure.

Anesthetic technique

EVT under LA with CS was considered for all patients with aneurysmal SAH, regardless of the Hunt and Hess (HH) scale score. The groin was infiltrated with 5 mL of 1% lidocaine. A low dose of intravenous remifentanil (0.02-0.1 μg/kg/min) was administered continuously for CS during the procedure. Ramsay sedation scale was used for assessment of the level of sedation [6]. Light sedation of Ramsay sedation scale at 2 or 3 was used to avoid respiratory depression, snoring, and maintain patient cooperation for neurologic evaluation. An additional bolus of low-dose of propofol or midazolam was administered if the procedure could not be continued due to patient immobility and agitation. Patients who were expected to exhibit unstable respiration were intubated for airway protection prior to the procedure and additional mechanical ventilation was applied to patients with respiratory failure due to initial neurologic severity. However, an anesthesiologist did not attend the administration of anesthetics, and inhaled anesthetics and muscle relaxant were not used, except for the continuous infusion of low-dose remifentanil and an additional bolus of midazolam or propofol, when necessary. These procedures allowed for neurologic examination of patients undergoing mechanical ventilation. We defined the procedure as being performed under LA with CS, according to whether or not neurologic examination was possible, regardless of the application of mechanical ventilation. We continuously monitored patients’ vital signs, including blood pressure, heart rate, respiratory rate, oxygen saturation, and electrocardiography.

Endovascular procedure

One neuroradiologist and one neurosurgeon performed each procedure. A radiolucent head-fixation device attached to the angiographic table was used to reinforce the immobility of the patient’s head. A bolus of intravenous heparin (50 IU/kg) was injected immediately after placement of the guiding catheter. Under fluoroscopic guidance, aneurysms were treated in accord with standard procedures, using appropriate microcatheters, microwires, coils, and stents, as indicated.

Angiographic follow-up

First and second follow-up radiologic examinations were performed using conventional catheter angiography at 6 months and 1.5 years after the initial procedure. If the second examination showed no recanalization or no change of minor recanalization, a third follow-up angiography was performed using magnetic resonance angiography (MRA) one year after the second follow-up. If conventional angiography was not feasible, the exams were performed using MRA with three-dimensional reconstruction. The angiographic outcomes were determined based on Raymond-Roy occlusion classification [7].

Statistical analysis

Statistical analyses were performed with SPSS version 21.0 software for window (SPSS Inc., Chicago, IL, USA). Univariate analysis using Fisher’s exact test, independent sample t-test, and Pearson’s χ2 test were used, as appropriate. Multivariate logistic regression was performed to assess the independent contributions of HH grade to morbidity, mortality, and the degree of aneurysm obliteration. The results were considered significant for P values <0.05.


Characteristics of patients and aneurysms

During the study period, a total of 308 consecutive patients harboring 399 aneurysms who had presented with aneurysmal SAH were treated via EVT. The study sample was composed of 123 men (39.9%) and 185 women (60.1%). The mean patient age was 55.5±12.6 (standard deviation) years. A total of 104 patients (33.7%) were age 61 or older. Eighty-eight patients (28.6%) exhibited hypertension, while 45 (14.6%) were smokers. Mild (I, II), moderate (III), and severe (IV, V) HH grades were noted in 156 (50.6%), 75 (24.4%), and 77 patients (25%), respectively. Sixty-six patients (21.4%) had multiple aneurysms, and 12 patients were treated for two aneurysms at the same time. Of the 320 aneurysms treated, most lesions involved the anterior (n=280, 87.5%), rather than the posterior circulation (n=40, 12.5%). The aneurysms were located in the following vessels: internal carotid artery (n=38, 11.8%), posterior communicating artery (n=66, 20.6%), middle cerebral artery (n=54, 16.8%), anterior communicating artery (n=101, 31.5%), anterior cerebral artery (n=21, 6.5%), and vertebrobasilar system (n=40, 12.5%). The mean aneurysm size was 6.2±3.5 mm and a total of 105 (32.8%) large aneurysms (7 mm or greater) were observed. Mean height-to-neck ratio of the aneurysms was 2.2±0.9. Table 1 shows the characteristics of patients and aneurysms.

Procedural results, complications, and clinical outcomes

The median door-to-puncture time was 2.73±0.33 hours, while mean procedure time was 2.26±1.1 hours. Simple coil embolization (CE), stent-assisted CE, balloon and stent-assisted CE were performed for 232 (72.5%), 71 (22.2%), and 17 aneurysms (5.3%), respectively. Complete occlusion (Raymond-Roy classification I) immediately after EVT was achieved for 270 (84.4%) of 320 aneurysms (Table 2). Procedure-related adverse events involving thromboembolic complications and intraprocedural ruptures occurred in 39 (12.1%) cases, 25 (7.8%) and 14 (4.3%), respectively.
Among the 308 included patients, EVT was completed under our protocol of anesthesia for 307 patients, while the remaining patient had extreme agitation and required conversion to general anesthesia with muscle relaxant and inhaled anesthetics under the supervision of an anesthesiologist. Seventy-three patients (23.7%) were intubated prior to the procedure and mechanical ventilation was applied for 34 patients (11.0%). Two patients of HH grade 3 underwent tracheal intubation and mechanical ventilation due to respiratory depression related CS during the procedures; however, the procedures were completed successfully. The morbidity rate at discharge (as defined by a modified Rankin scale score of 3 or greater) was 27.3% (84/308), while the mortality rate was 11.7% (36/308).

Follow-up angiographic results

Follow-up angiography results were available for 218 aneurysms of 210 (68.1%) patients. Conventional catheter angiography was used for most of these patients (conventional angiography: n=204, 97.1%; MRA only: n=6, 2.9%). The mean time to last angiographic follow-up was 18.4 months. Recanalization was observed in 64 (29.3%) of 218 aneurysms in 210 patients (Table 3). Twenty-eight of these aneurysms were retreated due to major recanalization. Adequate occlusion immediately after retreatment was achieved for 27 of 28 aneurysms.

Results according to HH grades

Good grade SAH group and poor grade SAH group were defined by HH grades 1 to 3 and 4 to 5, respectively. Clinical outcomes and procedural results between the good grade SAH group and the poor grade SAH group were compared (Table 4). The rates of tracheal intubation and application of mechanical ventilation were significantly higher in the poor grade SAH group than in the good grade SAH group (intubation rate: 72.7% versus 7.3%, odds ratio [OR] 34.0, 95% confidence interval [CI] 16.3-70.3, P<0.001; rate of application of mechanical ventilation: 35.1% versus 3.0%, OR 16.0, 95% CI 6.6-39.2, P<0.001). The mean size of aneurysms was significantly larger in the poor grade SAH group than in the good grade SAH group (7.16±4.31 mm versus 5.98±3.29 mm, P=0.016). The rates of morbidity and mortality were also significantly higher in the poor grade SAH group than in the good grade SAH group (morbidity: 53.2% versus 18.6%, P<0.001; mortality: 32.5% versus 4.8%, P<0.001). However, there was no significant differences in procedural complications, obliteration degree of aneurysms after initial procedure, or recanalization rate of follow-up angiography between the two groups.


In most centers, EVT for RIAs has been preferred under GA, which allows for airway protection, the maintenance of patient immobility for high image quality, and prevents sudden unexpected complications related to patient motion during the procedure [2]. However, LA allows for neurological evaluation during the procedure, shortens the procedure room time, and reduces complications that occur under general anesthesia and mechanical ventilation, such as cardiopulmonary morbidity and mortality [3,8,9]. In a systematic review and meta-analysis of 1,956 patients treated with LA or GA anesthesia types, Brinjikji et al. [8] reported that patients receiving general anesthesia had higher odds of mortality (OR 2.59, 95% CI 1.87-3.58, P<0.01), and respiratory complications (OR 2.09, 95% CI 1.36-3.23, P<0.01). Several studies have demonstrated that placement of a flow diverter and EVT for unruptured intracranial aneurysms can be performed safely under LA [10,11]. Ogilvy et al. [11] reported a high rate of successful procedure completion (74.6%) and low rates of overall procedure-related morbidity (1.2%) and mortality (0.6%), for a total of 496 unruptured aneurysms treated by LA with CS. In this study, even for non-selected RIAs, although mechanical ventilation was applied to 34 patients (11.0%), procedures were completed for most (307) of the 308 patients under CS, demonstrating the feasibility of EVT under LA with CS. Furthermore, to the best of our knowledge, this is the first large-scale study to present the long-term follow-up angiographic results of non-selected RIAs treated by EVT under LA with CS.
EVT may lead to procedure-related complications. Thromboembolic complications and intraprocedural perforation for intracranial aneurysms, including unruptured aneurysms under GA have been reported to occur in 11-12.5% and 2.5-5% of cases, respectively [12-15]. A previous study reported the rates of thromboembolic complications (7.7%) and intraprocedural rupture (3.8%) among patients with good grade SAH receiving CS [4]. Park et al. [5] reported a high rate of successful completion (98.4%) of RIAs treated by EVT under LA, but the intraoperative rupture rate (12.9%) was significantly higher for LA than GA, although thromboembolic rates (12.4%) were similar. This study showed a complication rate of 12.1% among patients with non-selected RIA, which included rates of thromboembolic events and intraprocedural perforation of 7.8% and 4.3%, respectively. There were also no significant differences in procedural complications, obliteration degree of aneurysms after the initial procedure, and recanalization rate seen at follow-up angiography between the good grade SAH group and the poor grade SAH group. However, the rates of tracheal intubation and application of mechanical ventilation were significantly higher in the poor grade SAH group than in the good grade SAH group. Therefore, airway protection may be required for patients with poor grade SAH, even if the procedures are performed under LA with CS.
A major concern associated with EVT for RIA is the risk of recanalization of a coiled aneurysm, which potentially re-bleeds. Previous studies have reported various rates of recanalization following EVT for intracranial aneurysms, including unruptured aneurysms under GA, ranging from 7.7% to 52.2% [16-18]. Several studies have reported that RIA is a risk factor for the recanalization of coiled aneurysms [17,18]. In this study, despite follow-up angiographic data collected primarily through conventional catheter angiography, the recanalization rate was 29.3%.
Re-bleeding is known to occur more frequently in the earlier phase after SAH, with the highest frequency occurring within the first 24 hours (15%), especially within the first 3-6 hours [19,20]. Previous studies advocated for treatment of aneurysms as early as possible after SAH because the risk of poor outcome increased as time-to-treatment after SAH increased [21-24]. In our study, EVT was initiated at a median of 2.73 hours after patients had arrived at the emergency room, and the mean procedure time was 2.26 hours. Early EVT was possible because there was no time required to prepare for GA, and it also shortened the total room time for the procedure.
Thus, our outcomes were comparable to the results of the above series performed under GA, as well as other studies under LA. Table 5 shows the summary of literature reports on EVT for RIA under GA.
Remifentanil is an ultra-short acting opioid which is quickly metabolized and does not accumulate in the tissue [25]. Continuous infusion of remifentanil with predictable pharmacokinetics has been used to achieve CS during various surgical procedures [26-28]. However, its continuous infusion can also cause respiratory depression and inhibition of the sympathetic nervous system, resulting in decreased heart rate and blood pressure [25]. A previous report demonstrated a higher incidence of respiratory depression in the CS group receiving remifentanil at an infusion rate of 0.1 μg/kg/min, compared to an infusion rate 0.05 μg/kg/min [28]. In this study, EVT for 89% of patients was completed without mechanical ventilation. However, severe respiratory depression occurred in two cases of CS and required urgent intubation during the procedures. These results highlight the caution that must be employed using LA with CS.
This study has several limitations. This study was a retrospective study performed at a single institution. As such, our results are susceptible to selection bias and the effects of an incomplete dataset. Furthermore, adverse events were self-reported, and we did not compare outcomes between those treated under LA and those treated under GA. Although light sedation of the Ramsay sedation scale at 2 or 3 was desired for appropriate CS, there is a possibility that a considerable number of patients were overly- sedated by infusion of sedative drugs. LA may not be suitable for patients who are extremely restless and are deemed too risky to be treated under this type of anesthesia. Nevertheless, we experienced the feasibility of EVT under LA with CS for non-selected RIAs, and we hope that a future large prospective multicenter trial will verify our findings.


LA does not allow for high-quality radiographic imaging during EVT, and patients may experience discomfort and pain during the procedure. However, based on our experience, EVT for non-selected RIAs under LA with CS is feasible, and the rates of procedural complication and immediate, follow-up angiographic results were also comparable with those observed following the use of GA.

Table 1.
Characteristics of patients and aneurysms
Variable Value
Patient demographics
 Age (years) 55.5±12.6
 >60 104 (33.7)
 Sex, male 123 (39.9)
 Hypertension 88 (28.6)
 Smoking 45 (14.6)
Hunt and Hess grade on admission
 Grade 1 5 (1.6)
 Grade 2 151 (49)
 Grade 3 75 (24.4)
 Grade 4 48 (15.6)
 Grade 5 29 (9.4)
Modified Fisher grade
 Grade 0 3 (1.0)
 Grade 1 90 (29.2)
 Grade 2 33 (10.7)
 Grade 3 93 (30.2)
 Grade 4 89 (28.9)
Location of the treated aneurysm 320
 Internal carotid artery 38 (11.8)
 Posterior communicating artery 66 (20.6)
 Middle cerebral artery 54 (16.8)
 Anterior communicating artery 101 (31.5)
 Anterior cerebral artery 21 (6.5)
 Vertebrobasilar artery 40 (12.5)
Aneurysm size
 Maximal diameter (mm) 6.2±3.5
 Diameter ≥7 mm 105 (32.8)
Multiplicity of aneurysm
 1 242 (78.5)
 2 44 (14.3)
 3 17 (5.5)
 4 4 (1.3)
 5 1 (0.3)
Height-to-neck ratio (mm) 2.2±0.9

Values are presented as number (%) or mean±standard deviation.

Table 2.
Results of initial procedure
Variable Value
Door-to-puncture time (hours) 2.73±0.33
Procedural time (hours) 2.26±1.1
Coiling techniques
 Simple coiling 232 (72.5)
 Stent assisted coiling 71 (22.2)
 Balloon and stent assisted coiling 17 (5.3)
Obliteration (RR)
 Class I 270 (84.4)
 Class II 45 (14.1)
 Class III 5 (1.5)
Procedural complication
 Thromboembolic events 25 (7.8)
 Intraprocedural rupture 14 (4.3)

RR, Raymond-Roy classification.

Values are presented as number (%) or mean±standard deviation.

Table 3.
Clinical outcomes on discharge and follow-up angiographic results
Variable Value
Clinical outcome on discharge 308
 Morbidity (mRS ≥3) 84 (27.3)
 Mortality 36 (11.7)
Follow-up angiography n=210
  Conventional angiography 204 (97.1)
  MRA 6 (2.9)
Recanalization 64 (29.3)
Obliteration of follow-up angiography (RR) 218
 Class I 136 (62.3)
 Class II 64 (29.3)
 Class III 18 (8.2)

mRS, modified Rankin scale; MRA, magnetic resonance angiography; RR, Raymond-Roy classification.

Values are presented as number (%).

Table 4.
Comparison between good grade SAH group and poor grade SAH group
Good grade SAH group (n=231) Poor grade SAH group (n=77) P value
Age (years) 55.1±12.8 56.8±12.1 0.324
Male 89 (38.5) 34 (44.2) 0.421
Hypertension 62 (26.8) 26 (33.8) 0.243
Aneurysms treated 241 79
 Anterior circulation 211 (87.6) 69 (87.3) 1.000
 Size (mm) 5.98±3.29 7.16±4.31 0.016
Intubation 17 (7.3) 56 (72.7) <0.01
Mechanical ventilation 7 (3.0) 27 (35.1) <0.01
Morbidity 43 (18.6) 41 (53.2) <0.01*
Mortality 11 (4.8) 25 (32.5) <0.01*
Door to puncture time (hours) 2.8 (0.57-31) 2.7 (1.5-71.8) 0.883
Procedure time (hours) 2.4±1.1 2.1±1.2 0.054
Thromboembolic events 20 (8.6) 5 (6.5) 0.637
Intraprocedural rupture 13 (5.3) 1 (1.3) 0.202
Obliteration after initial procedure (RR) 0.123*
 Class I 205 (85.1) 66 (83.5)
 Class II 35 (14.5) 9 (11.4)
 Class III 1 (0.4) 4 (5.1)
Recanalization on follow-up angiography 55 (29.1) 9 (31.9) 0.829

SAH, subarachnoid hemorrhage; RR, Raymond-Roy classification.

Values are presented as number (%), mean±standard deviation, or median (range).

* Multivariate logistic regression was performed for analysis.

Table 5.
Summary of the literatures on EVT under GA for RIA
Author Study N TT TE IPR CO RC
Raymond et al. (2003) [18] R 191 NA NA NA NA 39.8%
Park et al. (2005) [12] R 118 NA 11.0% 7.6% 62.7% NA
van Rooij et al. (2006) [29] R 681 NA 4.7% 4.4% NA NA
Bruening et al. (2006) [30] R 225 NA 7.1% 4.3% NA NA
Nguyen et al. (2007) [17] R 44 NA NA NA 41.9% 52.2%
Deng et al. (2007) [31] R 102 NA 5.8% 8.8% 61.8% NA
Bradac et al. (2007) [32] R 533 <2 days 6.6% 3.9% NA NA
Yu et al. (2007) [33] R 80 <3 days 2.5% 0.0% 83.8% 7.7%
Ries et al. (2007) [16] R 323* NA NA NA 69.6% 21.1%
Nguyen et al. (2008) [34] R 682 NA NA 3.1% NA NA
Elijovich et al. (2008) [14] R 299 NA NA 5.0% NA NA
Fiehler et al. (2008) [35] P 186 NA 10.8% 4.5% NA NA
Renowden et al. (2009) [36] R 711 <1 day 4.5% 4.7% NA NA
Linfante et al. (2010) [37] R 184 NA 10.3% NA NA NA
Pierot et al. (2008) [38] P 782 NA 12.5% NA NA NA
Cho et al. (2012) [39] R 372 NA 10.5% NA NA NA
Kang et al. (2014) [40] R 322 NA NA 4.8% NA NA
Stapleton et al. (2015) [41] R 156 NA NA 7.7% NA NA
Spetzler et al. (2015) [42] P 126 NA NA NA 57.9% NA
Fan et al. (2017) [43] R 231 NA 6.5% 4.3% NA NA
Nomura et al. (2018) [44] R 70 NA 7.1% NA NA NA
Present study R 308 2.73 hours 7.8% 4.3% 84.4% 29.3%

EVT, endovascular treatment; GA, general anesthesia; RIA, ruptured intracranial aneurysm; N, patient number; TT, timing of treatment; TE, thromboembolic events; IPR, intraprocedural rupture; CO, complete obliteration; RC, recanalization; R, retrospective study; NA, not assessed; P, prospective study.

* Number of patients including unruptured intracranial aneurysms.


1. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002; 360: 1267-74.
crossref pmid pmc
2. Joung KW, Yang KH, Shin WJ, Song MH, Ham K, Jung SC, et al. Anesthetic consideration for neurointerventional procedures. Neurointervention 2014; 9: 72-7.
crossref pmid pmc
3. Davis MJ, Menon BK, Baghirzada LB, Campos-Herrera CR, Goyal M, Hill MD, et al. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology 2012; 116: 396-405.
crossref pmid
4. Kan P, Jahshan S, Yashar P, Orion D, Webb S, Siddiqui AH, et al. Feasibility, safety, and periprocedural complications associated with endovascular treatment of selected ruptured aneurysms under conscious sedation and local anesthesia. Neurosurgery 2013; 72: 216-20.
crossref pmid pdf
5. Park SD, Kim JH, Chang CH, Jung YJ. Procedure-related complication rate for the endovascular treatment of aneurysmal subarachnoid hemorrhage under local anesthesia. J Cerebrovasc Endovasc Neurosurg 2016; 18: 215-22.
crossref pmid pmc
6. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2: 656-9.
crossref pmid pmc
7. Roy D, Milot G, Raymond J. Endovascular treatment of unruptured aneurysms. Stroke 2001; 32: 1998-2004.
crossref pmid
8. Brinjikji W, Murad MH, Rabinstein AA, Cloft HJ, Lanzino G, Kallmes DF. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2015; 36: 525-9.
crossref pmid
9. Forrest JB, Rehder K, Cahalan MK, Goldsmith CH. Multicenter study of generalanesthesia. III. Predictors of severe perioperative adverse outcomes. Anesthesiology 1992; 76: 3-15.
crossref pmid
10. Griessenauer CJ, Shallwani H, Adeeb N, Gupta R, Rangel-Castilla L, Siddiqui AH, et al. Conscious sedation versus general anesthesia for the treatment of cerebral aneurysms with flow diversion: a matched cohort study. World Neurosurg 2017; 102: 1-5.
crossref pmid
11. Ogilvy CS, Yang X, Jamil OA, Hauck EF, Hopkins LN, Siddiqui AH, et al. Neurointerventional procedures for unruptured intracranial aneurysms under procedural sedation and local anesthesia: a large-volume, single-center experience. J Neurosurg 2011; 114: 120-8.
crossref pmid
12. Park HK, Horowitz M, Jungreis C, Genevro J, Koebbe C, Levy E, et al. Periprocedural morbidity and mortality associated with endovascular treatment of intracranial aneurysms. AJNR Am J Neuroradiol 2005; 26: 506-14.
13. Pierot L, Cognard C, Anxionnat R, Ricolfi F; CLARITY Investigators. Ruptured intracranial aneurysms: factors affecting the rate and outcome of endovascular treatment complications in a series of 782 patients (CLARITY study). Radiology 2010; 256: 916-23.
crossref pmid
14. Elijovich L, Higashida RT, Lawton MT, Duckwiler G, Giannotta S, Johnston SC, et al. Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms: the CARAT study. Stroke 2008; 39: 1501-6.
crossref pmid
15. Fiehler J, Byrne JV. Factors affecting outcome after endovascular treatment of intracranial aneurysms. Curr Opin Neurol 2009; 22: 103-8.
crossref pmid
16. Ries T, Siemonsen S, Thomalla G, Grzyska U, Zeumer H, Fiehler J. Long-term follow-up of cerebral aneurysms after endovascular therapy prediction and outcome of retreatment. AJNR Am J Neuroradiol 2007; 28: 1755-61.
crossref pmid
17. Nguyen TN, Hoh BL, Amin-Hanjani S, Pryor JC, Ogilvy CS. Comparison of ruptured vs unruptured aneurysms in recanalization after coil embolization. Surg Neurol 2007; 68: 19-23.
crossref pmid
18. Raymond J, Guilbert F, Weill A, Georganos SA, Juravsky L, Lambert A, et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke 2003; 34: 1398-403.
crossref pmid
19. Javadpour M, Silver N. Subarachnoid haemorrhage (spontaneous aneurysmal). BMJ Clin Evid 2009; 2009: 1213.
pmid pmc
20. Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 2001; 32: 1176-80.
crossref pmid
21. Dorhout Mees SM, Molyneux AJ, Kerr RS, Algra A, Rinkel GJ. Timing of aneurysm treatment after subarachnoid hemorrhage: relationship with delayed cerebral ischemia and poor outcome. Stroke 2012; 43: 2126-9.
crossref pmid
22. Whitfield PC, Kirkpatrick PJ. Timing of surgery for aneurysmal subarachnoidhaemorrhage. Cochrane Database Syst Rev 2001; (2):CD001697.
23. de Gans K, Nieuwkamp DJ, Rinkel GJ, Algra A. Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature. Neurosurgery 2002; 50: 336-40.
24. Baltsavias GS, Byrne JV, Halsey J, Coley SC, Sohn MJ, Molyneux AJ. Effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes. Neurosurgery 2000; 47: 1320-9. discussion 1329-31.
crossref pmid pdf
25. Bürkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short-acting, mu-opioid. Anesth Analg 1996; 83: 646-51.
crossref pmid
26. Goettel N, Bharadwaj S, Venkatraghavan L, Mehta J, Bernstein M, Manninen PH. Dexmedetomidine vs propofol-remifentanil conscious sedation for awake craniotomy: a prospective randomized controlled trial. Br J Anaesth 2016; 116: 811-21.
crossref pmid pmc pdf
27. Byun SH, Hwang DY, Hong SW, Kim SO. Target-controlled infusion of remifentanil for conscious sedation during spinal anesthesia. Korean J Anesthesiol 2011; 61: 195-200.
crossref pmid pmc
28. Cannata F, Spinoglio A, Di Marco P, Luzi M, Canneti A, Ricciuti G, et al. Total intravenous anesthesia using remifentanil in extracorporeal shock wave lithotripsy (ESWL). Comparison of two dosages: a randomized clinical trial. Minerva Anestesiol 2014; 80: 58-65.
29. van Rooij WJ, Sluzewski M, Beute GN, Nijssen PC. Procedural complications of coiling of ruptured intracranial aneurysms: incidence and risk factors in a consecutive series of 681 patients. AJNR Am J Neuroradiol 2006; 27: 1498-501.
30. Bruening R, Mueller-Schunk S, Morhard D, Seelos KC, Brueckmann H, Schmid-Elsaesser R, et al. Intraprocedural thrombus formation during coil placement in ruptured intracranial aneurysms: treatment with systemic application of the glycoprotein IIb/IIIa Antagonist tirofiban. AJNR Am J Neuroradiol 2006; 27: 1326-31.
31. Deng J, Zhao Z, Gao G. Periprocedural complications associated with endovascular embolisation of intracranial ruptured aneurysms with matrix coils. Singapore Med J 2007; 48: 429-33.
32. Bradac GB, Bergui M, Stura G, Fontanella M, Daniele D, Gozzoli L, et al. Periprocedural morbidity and mortality by endovascular treatment of cerebral aneurysms with GDC: a retrospective 12-year experience of a single center. Neurosurg Rev 2007; 30: 117-25.
crossref pmid
33. Yu SC, Wong GK, Wong JK, Poon WS. Endovascular coiling versus neurosurgical clipping for ruptured intracranial aneurysms: significant benefits in clinical outcome and reduced consumption of hospital resources in Hong Kong Chinese patients. Hong Kong Med J 2007; 13: 271-8.
34. Nguyen TN, Raymond J, Guilbert F, Roy D, Bérubé MD, Mahmoud M, et al. Association of endovascular therapy of very small ruptured aneurysms with higher rates of procedure-related rupture. J Neurosurg 2008; 108: 1088-92.
crossref pmid
35. Fiehler J, Boor S, Dörbecker R, Eckert B, Götz F, Hartmann M, et al. Table for optimization and monitoring of cerebral aneurysm therapy (TOMCAT). Clin Neuroradiol 2008; 18: 168-76.
36. Renowden SA, Benes V, Bradley M, Molyneux AJ. Detachable coil embolisation of ruptured intracranial aneurysms: a single center study, a decade experience. Clin Neurol Neurosurg 2009; 111: 179-88.
crossref pmid
37. Linfante I, Etezadi V, Andreone V, DeLeo M, Alehashemi S, Shaw K, et al. Intra-arterial abciximab for the treatment of thrombus formation during coil embolization of intracranial aneurysms. J Neurointerv Surg 2010; 2: 135-8.
crossref pmid
38. Pierot L, Spelle L, Vitry F, ATENA Investigators. Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: results of the ATENA study. Stroke 2008; 39: 2497-504.
crossref pmid
39. Cho YD, Lee JY, Seo JH, Kang HS, Kim JE, Jung KH, et al. Intraarterial tirofiban infusion for thromboembolic complication during coil embolization of ruptured intracranial aneurysms. Eur J Radiol 2012; 81: 2833-8.
crossref pmid
40. Kang DH, Goh DH, Baik SK, Park J, Kim YS. Morphological predictors of intraprocedural rupture during coil embolization of ruptured cerebral aneurysms: do small basal outpouchings carry higher risk? J Neurosurg 2014; 121: 605-12.
crossref pmid
41. Stapleton CJ, Walcott BP, Butler WE, Ogilvy CS. Neurological outcomes following intraprocedural rerupture during coil embolization of ruptured intracranial aneurysms. J Neurosurg 2015; 122: 128-35.
crossref pmid
42. Spetzler RF, McDougall CG, Zabramski JM, Albuquerque FC, Hills NK, Russin JJ, et al. The barrow ruptured aneurysm trial: 6-year results. J Neurosurg 2015; 123: 609-17.
crossref pmid
43. Fan L, Lin B, Xu T, Xia N, Shao X, Tan X, et al. Predicting intraprocedural rupture and thrombus formation during coiling of ruptured anterior communicating artery aneurysms. J Neurointerv Surg 2017; 9: 370-5.
crossref pmid
44. Nomura M, Mori K, Tamase A, Kamide T, Seki S, Iida Y, et al. Thromboembolic complications during endovascular treatment of ruptured cerebral aneurysms. Interv Neuroradiol 2018; 24: 29-39.
crossref pmid
Editorial Office
88, Olympic-ro 43-gil, Songpa-gu, Seoul, Korea
TEL : +82-2-3010-3440    FAX : +82-2-474-4691    E-mail : office@e-jnc.org

Copyright© Korean Neurocritical Care Society. All rights reserved.                powerd by M2community
About |  Browse Articles |  Current Issue |  For Authors and Reviewers